The biotech’s first product for something other than Covid doesn’t clearly perform any better than other shots on the market.

said the likely key reason for the withdrawal was the fact that other Covid vaccines, including the messenger RNA (mRNA) vaccines from Pfizer and Moderna, were “essentially better products.” ...

Jacobs said Sanofi, as a large pharmaceutical company, could increase the market share and presence of Novavax's Covid ...

Amid the safety concerns over AstraZeneca's Covid vaccine Covishield and Vaxzevria, the pharmaceutical giant on Tuesday said it has initiated to withdraw its Vaxzevria vaccine globally ...

AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy. The jab, developed at Oxford University ...

News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...

Anti-vaxxers today called for Pfizer and Moderna to urgently withdraw their Covid jabs ... AstraZeneca's vaccine withdrawal saw its shares hit a record high. The firm's share prices were up ...

Because the vaccine trains the immune system to target proteins that are shared across many different types of coronavirus, the protection it induces is extremely broad, making it effective ...

By Rebecca Robbins All vaccines have at least occasional side effects. But people who say they were injured by Covid vaccines believe their cases have been ignored. By Apoorva Mandavilli ...

The company expects the first batches of the COVID-19 vaccine, JNJ-78436735 ... The average price target represents a 14.23% increase from the last price of $146.07. All those seven equity ...

The US pharma giant seeks to regain profits through cancer treatment drugs since the demand for its Covid-19 vaccines has plummeted The ... pharma giant got its hands on the drug, its CEO said. An ...